AstraZeneca and Daiichi Sankyo have moved swiftly to file for FDA approval of a second indication for their TROP2-directed antibody-drug conjugate datopotamab deruxtecan (Dato-DXd), this time for ...

A biomarker could help identify patients with lung cancer who are most likely to benefit from treatment with AstraZeneca and Daiichi Sankyo's TROP2-directed drug datopotamab deruxtecan (Dato-DXd). The ...

At close: December 24 at 1:00:00 PM EST ...

What if Naruto United All Factions by Marrying Their Strongest Female Warriors of dxd Naruto And High School DXD Fanfics and AMV 94 followers Follow 0 0 ...

Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...